Market Risers: Boohoo.Com PLC, Centrica PLC, Fresnillo Plc, GlaxoSmithKline plc

boohoo.com plc
[shareaholic app="share_buttons" id_name="post_below_content"]

The trading price for Boohoo.Com PLC company symbol: LON:BOO has climbed 4.31% or 6.35 points during today’s session so far. Investors have remained optimistic during the session. The periods high figure was 155 and hitting a low of 144.65. Volume total for shares traded at this point reached 7,688,639 whilst the daily average number of shares exchanged is just 8,697,131. The 52 week high price for the shares is 328.93 about 181.58 points in difference to the previous days close of business and a 52 week low sitting at 1.89 making a difference of 145.46 points. Boohoo.Com PLC has a 20 SMA of 177.68 and now the 50 day moving average now of 183.72. This puts the market cap at £1,766.77m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Boohoo.Com PLC being recorded at Friday, March 23, 2018 at 12:27:19 PM GMT with the stock price trading at 153.7 GBX.

 

 

Shares of Centrica PLC with EPIC code: LON:CNA has gained 1.78% or 2.35 points during today’s session so far. Traders have stayed positive during the session. The high for the period has reached 134.5 while the low for the session was 131.9. The number of shares traded by this point in time totalled 8,945,013 with the daily average number around 27,479,517. The 52 week high for the share price is 221 which is 89.1 points difference from the previous days close and the 52 week low at 119.71 a difference of some 12.19 points. Centrica PLC now has a 20 simple moving average of 141.75 and now its 50 day SMA of 137.6. This puts the market cap at £7,519.33m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Centrica PLC being recorded at Friday, March 23, 2018 at 12:26:32 PM GMT with the stock price trading at 134.25 GBX.

 

 

Shares in Fresnillo Plc EPIC code: LON:FRES has moved up 2.89% or 33.5 points in today’s trading session so far. Traders seem confident during the trading session. The high for the period has reached 1193.5 meanwhile the session low reached 1160. The amount of shares exchanged has so far reached 415,166 whilst the average number of shares exchanged is 1,181,788. The 52 week high for the shares is 1746 equating to 586.5 points difference from the previous close and the 52 week low at 1150.5 which is a difference of 9 points. Fresnillo Plc now has a 20 SMA of 1236.9 and the 50 day moving average now at 1313.01. This puts the market capitalisation now at £8,819.23m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Fresnillo Plc being recorded at Friday, March 23, 2018 at 12:27:29 PM GMT with the stock price trading at 1193 GBX.

 

 

The stock price for GlaxoSmithKline plc with EPIC code: LON:GSK has stepped up 4.32% or 55 points during the course of today’s session so far. Market buyers seem confident during the session. The periods high figure was 1349.2 and hitting a low of 1301.4. The total volume traded so far comes to 9,045,872 with the daily average number around 8,350,314. The 52 week high price for the shares is 1724.5 which is 450.7 points in difference on the previous days close and a 52 week low being 1235.2 is a variance of 38.59 points. GlaxoSmithKline plc has a 20 day moving average of 1319.99 and now a 50 day MA at 1327.67. This puts the market cap at £65,893.42m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Friday, March 23, 2018 at 12:27:03 PM GMT with the stock price trading at 1328.8 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Centrica plc announces Kevin O'Byrne as new Chair and Jo Harlow as Senior Independent Director, with Scott Wheway stepping down today.
GSK's Jemperli receives FDA Breakthrough Therapy Designation for treating locally advanced dMMR/MSI-H rectal cancer, expediting crucial development.
Centrica plc (LON:CNA) reports strategic progress and stable 2024 earnings, as it hosts an investor teach-in on Centrica Energy and MAP businesses today.
GSK announces FDA review of Nucala for COPD treatment following successful MATINEE study data, aiming to be the first approved monthly biologic.

Search

Search